RNA-Bound MYBL2 Engages the Oncogenic Transcription Factors MAFG and FRA1 to Promote Melanoma Progression

Non-mutational mechanisms, including copy number alterations and transcription factor dysregulation, are critical drivers of melanoma progression. Here, we identify the transcription factor MYBL2 as a key oncogenic driver located on frequently amplified chromosome 20q. MYBL2 overexpression promoted transformation and correlated with poor survival, yet paradoxically, the transactivation function of MYBL2 was dispensable for oncogenic activity. Instead, MYBL2 acquired a non-canonical RNA-binding function enabled by the melanoma-associated RNA landscape. Through these RNA interactions, MYBL2 reshaped the chromatin landscape toward an AP-1-permissive state and promoted chromatin association of the oncogenic transcription factors MAFG and FRA1, indirectly reprogramming tumor-promoting gene networks that predict poor outcomes across multiple cancers. Importantly, a decoy RNA that disrupts the MYBL2-RNA interaction impaired MYBL2 association with MAFG and FRA1 and suppressed melanoma cell growth. These findings establish MYBL2 as an RNA-binding-dependent, 20q gain-associated driver that promotes melanoma progression through chromatin and transcriptional network remodeling.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-11-13
DOI
https://doi.org/10.1158/0008-5472.can-26-4122
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

RNA-Bound MYBL2 Engages the Oncogenic Transcription Factors MAFG and FRA1 to Promote Melanoma Progression

Shiun Chang, Jennifer M. Binning, Florian A. Karreth, Nicol Mecozzi et al.
1 links
Cancer Research
Melanoma and MAPK Pathways
article

RNA-Bound MYBL2 Engages the Oncogenic Transcription Factors MAFG and FRA1 to Promote Melanoma Progression

Shiun Chang, Jennifer M. Binning, Florian A. Karreth, Nicol Mecozzi, Manon Chadourne, Olga Vera, Sean Yoder, Kaizhen Wang, Xiaoqing Yu, Dongliang Du, Zulaida Soto-Vargas, Xiaonan Xu, Jameela Lokhandwala, Rachel P. Kogan, Nhan Phan
article en

Abstract

Non-mutational mechanisms, including copy number alterations and transcription factor dysregulation, are critical drivers of melanoma progression. Here, we identify the transcription factor MYBL2 as a key oncogenic driver located on frequently amplified chromosome 20q. MYBL2 overexpression promoted transformation and correlated with poor survival, yet paradoxically, the transactivation function of MYBL2 was dispensable for oncogenic activity. Instead, MYBL2 acquired a non-canonical RNA-binding function enabled by the melanoma-associated RNA landscape. Through these RNA interactions, MYBL2 reshaped the chromatin landscape toward an AP-1-permissive state and promoted chromatin association of the oncogenic transcription factors MAFG and FRA1, indirectly reprogramming tumor-promoting gene networks that predict poor outcomes across multiple cancers. Importantly, a decoy RNA that disrupts the MYBL2-RNA interaction impaired MYBL2 association with MAFG and FRA1 and suppressed melanoma cell growth. These findings establish MYBL2 as an RNA-binding-dependent, 20q gain-associated driver that promotes melanoma progression through chromatin and transcriptional network remodeling.

Cancer Research
University of South Florida (US), Moffitt Cancer Center (US), Hospital La Paz Institute for Health Research (ES)
National Institutes of Health, National Cancer Institute
Good health and well-being
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon